Introduction
Secretory proteins are targeted into either constitutive or regulated pathways ( 1, 2). Proteins entering the regulated pathway are concentrated and stored in vesicles, and subsequently released upon stimulation by a secretagogue. In the constitutive pathway, newly synthesized protein is not stored but leaves the Golgi complex in short-lived membrane vesicles that fuse immediately with the plasma membrane even in the absence of any extracellular signal.
Catecholamine storage vesicles are specialized subcellular organelles within chromaffin cells of the adrenal medulla and in sympathetic neurons (3) . In addition to catecholamines, 5), all ofwhich are released in response to secretagogues by the process ofexocytosis (6) . These vesicles are thus an example of regulated secretory vesicles. The mechanisms of assembly of catecholamine storage vesicles, and, in particular, how proteins are targeted to such vesicles are poorly understood.
Chromogranin A (CgA)1 is the major soluble protein in the core of catecholamine storage vesicles (7) and is found as well in dense core secretory vesicles throughout the neuroendocrine system (8-1 1 ). In addition, recent evidence suggests that CgA and other members of the chromogranin/secretogranin ("granin") family of proteins may have a central role in the packaging of other proteins into the regulated secretory pathway (12) . Thus, CgA may be a model protein for studies of protein targeting into the regulated pathway of secretion. Also, CgA is the source of biologically active peptides, such as pancreastatin ( 13) , which suppresses islet beta cell secretion, and chromostatin, which suppresses secretagogue-stimulated catecholamine release ( 14) .
To investigate mechanisms of protein targeting into catecholamine storage vesicles, we expressed human chromogranin A in the rat PC-12 cell line, a catecholaminergic rat pheochromocytoma cell line ( 15 ) , which exhibits both regulated and constitutive pathways for secretion and sorts secreted proteins into one or the other ofthese pathways ( 16, 17) . In the present report, we demonstrate the expression of human CgA in rat pheochromocytoma cells, the targeting of expressed human CgA to dense core catecholamine storage vesicles, and the ability of human CgA to divert a heterologous, ordinarily nonsecreted protein (chloramphenicol acetyltransferase [CAT]) into the regulated secretory pathway. In addition, we demonstrate that information sufficient for regulated vesicular targeting is contained within the amino-terminal half of the human CgA peptide sequence.
Methods

Construction ofthe expression vector, pRSV-hCgA
The mammalian expression vector, pRSV-hCgA, containing the fulllength human CgA cDNA under the control ofthe Rous sarcoma virus long-terminal repeat (RSV-LTR) was constructed as shown in Fig. 1 . pGEM-hCgA (from Dr. Lee Helman, National Cancer Institute) was the source of the human CgA cDNA ( 18 ) . pRSV-L (from Dr. Suresh Subramani, University ofCalifornia, San Diego) ( 19) was the source of the RSV-LTR. After conversion of the SmaI site to an XhoI site in pRSV-L with synthetic linkers and subsequent digestion of resultant vector pRSV-L, with HindIII and XhoI to remove the firefly luciferase gene, the human CgA cDNA (liberated from pGem-hCgA by digestion with HindIII and Sal I) was spliced into this HindIII-XhoI site. (Cohe- Figure 1 . Construction of the expression vector, pRSV-hCgA, containing the full-length human CgA cDNA under the control of the RSV-LTR. pGEMhCgA was the source of the human CgA cDNA ( 18) . pRSV-L was the source ofthe RSV-LTR ( 19) . After conversion of the SmaI site to an XhoI site in pRSV-L with synthetic linkers and subsequent digestion of pRSV-Lj with HindIll and XhoI to remove the firefly luciferase gene, the human CgA cDNA (liberated from pGem-hCgA by digestion with HindIll and SalI) was spliced into this HindIII-XhoI site. (Cohesive ends from XhoI and SalI digestions are compatible; subsequent ligation results in loss of SalI and XhoI recognition sites and generation of a TaqI site.) The resultant construct contains the human CgA cDNA under the control of RSV-LTR, SV40 small t splice signal and polyadenylation signal (An) for efficient message processing, and a prokaryotic segment from pBR-322 including the origin of replication (ori) and fl-lactamase gene (ampR) for growth in E. coli. sive ends from XhoI and SalI digestions are compatible; subsequent ligation results in loss ofSalI and XhoI recognition sites and generation ofa TaqI site.) The resultant construct contains the human CgA cDNA under the control ofRSV-LTR, an SV40 small t splice signal and polyadenylation signal (A.) for efficient message processing, and a prokaryotic segment from pBR-322 including the origin of replication (ori) and fl-lactamase gene (ampR) for growth in Escherichia coli. Construction was verified by diagnostic restriction digests and DNA sequencing.
Cell culture
Rat pheochromocytoma PC-12 cells (obtained from Dr. Bruce Howard of University of California, Los Angeles) were grown at 370C, 6% C02, in 10-cm plates in DME medium supplemented with 5% FCS, 10% horse serum, 100 U/ml penicillin, and 100 jig/ml streptomycin.
Stable transfection ofrat pheochromocytoma PC-12 cells
Using the calcium phosphate method (20) , PC-12 cells (at 20-30% confluence) were cotransfected with 10 ,ug pRSV-hCgA plus 2 jg ofthe plasmid pSV2-neo (21 ) , which encodes bacterial phosphostransferase and confers neomycin resistance. Control cells were transfected with pSV2-neo alone. Transfected cells were selected with the antibiotic Geneticin (G418; Gibco BRL Life Technologies, Inc., Gaithersburg, MD) at 0.5 mg/ml (active). Individual stable clones were recovered, transferred to separate wells of24-well plates for subculture, and grown to mass culture in 10-cm plates. Homogenates of stably transfected cells were obtained by resuspension of harvested cell pellets in 50 mM ammonium acetate, pH 6.5, 0.1% Triton X-100, followed by two freeze-thaw cycles to promote cell disruption. Homogenates were screened for the production of human CgA by RIA specific for human CgA (22) .
SDS-PAGE and immunoblotting
Prestained molecular weight size standards, 15 ug of protein from human pheochromocytoma chromaffin vesicle lysate, and 50 ,g of protein from cell lysates of PC-12 cells transfected with either pSV2-neo alone or pSV2-neo and pRSV-hCgA, were electrophoresed through 10% SDS-PAGE slab gels, transferred to nitrocellulose, and stained for immunoreactive human CgA with rabbit anti-human CgA antisera (22) I   I   I   I   I to remove growth media, and fixed at room temperature in modified Karnovsky's solution for 30 min. After three buffer washes with 0.2 M sodium cacodylate (pH 7.4), the cells were postfixed in buffered 1% osmium tetroxide for 30 min. After three distilled water rinses, the cells were dehydrated in a graded ethanol series (3 min each) followed by a 10-min wash series in (90%, 95%, 97%) hydroxypropyl methacrylate. After dehydration, the cells were embedded in a thin layer (approximately one-fourth the depth ofthe dish) ofEpon 812. Afterpolymerization in a 650C oven, the hardened plastic containing the cells was removed from the dish and floated for 15 KCl as secretagogue included NaCI at 100 mM and release buffer was devoid ofCaCl2 when BaCl2 was used as secretagogue.) After aspirating the release buffer, cells were harvested and lysed in 150 mM NaCl, 5 mM KCI, 10 mM Hepes, pH 7, and 0.1% Triton X-100. Release buffer and cell lysates were assayed for human CgA by RIA and [3H]-norepinephrine by liquid scintillation counting, and results were expressed as percent secreted: amount in release buffer/total (amount in release buffer + amount in cell lysate). In addition, release of norepinephrine and human CgA from transfected PC-12 cells was determined after exposure for 30 min to the weak bases chloroquine at 1 mM or ammonium chloride at 10 mM.
Human CgA radioimmunoassay Human CgA was assayed as previously described by species specific RIA, which recognizes human but not rat (including endogenous PC-12) epitopes (22) .
Protein concentrations on lysates oftransfected cells and on lysates of chromaffin vesicles prepared from human pheochromocytoma tumors (5) were determined by the Coomassie Blue dye binding technique (27) .
Human CgA/CATfusion studies Construction ofthe expression vectors pRSV-hCgA457CATandpRSV-hCg4226-CA T. An expression vector (pRSV-hCgA4,CAT) encoding a chimeric protein consisting offull-length human CgA fused in-frame to the bacterial enzyme CAT was constructed as diagrammed in Fig. 2 3 ' primer) into the 5' and 3' termini ofthe final 1.4-kb product, using 35 cycles of 94°C for 1 min, 42°C for 1 min, and 65°C for 1.5 min, in an EZ Cycler thermocycler (Ericomp., Inc., San Diego, CA). The product contained the full open reading frame of human CgA but was altered by the 3' primer such that the stop codon of the initial human CgA cDNA was substituted with the codon AGC, encoding a serine residue and allowing translation to continue through this point; the PCR product was digested at 37°C for 18 h with Hind III, purified on a 1% agarose gel, and ligated into the unique Hind III site of the expression vector pRSV-CAT (30) . The resultant construct contains the RSV-LTR promoter driving full-length human CgA cDNA (encoding 457 amino acid residues) fused in-frame to the full-length CAT-encoding region. Also, since the Hind III cloning site in pRSV-CAT is 36 bp upstream of the ATG initiation codon for CAT, expression of the final fusion product results in the insertion of an additional 12 amino acid residues (SLARFSGAKEAKM) between full-length human CgA and CAT.
An additional expression vector (pRSV-hCgA226-CAT) containing a mutated human CgA cDNA encoding the amino-terminal 226 amino acid residues of human CgA (including the 18-residue signal peptide plus the amino-terminal 208 residues of mature CgA after signal peptide cleavage) fused in-frame to CAT was also constructed using the above PCR methods with 5'-AAATAAGCTTCGGCCCCACACC-GCCA-3' as 5' primer and 5'-AAATAAGCTTGCCTGCCACCCT-GG-3' as the 3' primer and full-length human CgA cDNA as template. The resultant 0.7-kb product was digested with Hind III and inserted into the Hind III cloning site of pRSV-CAT as above. The final construct contains the coding region for the amino-terminal 226 amino acid residues of human CgA fused in-frame to the coding region for of the expression vector pRSV-CAT (30) . The vector pRSV-hCgA226-CA T containing a mutated human CgA cDNA encoding the amino-terminal 226 amino acid residues of human CgA (including the 18-residue signal peptide plus the amino-terminal 208 residues of mature CgA after signal peptide cleavage) fused in frame to CAT was constructed using PCR methods with the primers, 5'-AAATAAGCTTCGGCCCCACACC-GCCA-3' as 5' primer and 5'-AAATAAGCTTGCCTGCCACCCTGG-3' as the 3' primer and the full-length human CgA cDNA as template (lower box). The resultant 0.7-kb product was digested with Hind III and inserted into the Hind III cloning site of pRSV-CAT as above. CAT, under the control ofthe RSV-LTR. Expression ofthe final fusion product of this vector results in the insertion (between the 226 aminoterminal amino acid residues of human CgA and CAT) of the same additional 12 amino acid residues (SLARFSGAKEAKM) described above for pRSV-hCgA45,-CAT. Both of these expression vectors (pRSV-hCgA457-CAT and pRSV-hCgA226-CAT) were analyzed by restriction endonuclease mapping to confirm orientations, and fragment junctions were confirmed by DNA sequencing in both cases.
Transient transfection of PC-12 cells. PC-12 cells grown to 50% confluence in 6-cm plates were transfected using the lipofection procedure (31, 32) with 20 ,ug ofplasmid DNA (either pRSV-hCgA457-CAT, pRSV-hCgA226-CAT, pRSV-CAT, or pBluescript [Stratagene, Inc., La Jolla, CA] as a mock transfection control) and 20 ,ug of lipofectant (Gibco BRL Life Technologies, Inc.). After 48-60 h, transfected cells were analyzed by metabolic labeling and immunoprecipitation to confirm translation products, or by secretagogue-stimulation to investigate corelease of [3H ]norepinephrine and CAT activity as described below.
Metabolic labeling and immunoprecipitation. Transiently transfected PC-12 cells were starved for 1 h in methione-free medium, then labeled with 50 MCi/plate [35S]methionine (ICN Biochemicals, Inc., Costa Mesa, CA) for 4 h at 370C. Cells were washed with PBS and lysed in 0.1 M NaCl, 0.1 M Tris, pH 8.0, 10 mM EDTA, 1% Triton X-100, 1 mM PMSF (Sigma Chemical Co.), and 50 KIU/ml aprotinin (Calbiochem Corp., La Jolla, CA). Cell debris was removed by centrifugation and 75 Al of each of the cell supernatants were incubated with 2 M1 of preimmune serum for 1 h at 4°C, followed by 10 Ml 50% protein A Sepharose (Pharmacia-LKB Biotechnology, Inc., Piscataway, NJ) for 30 min at 4°C on a shaker platform, to reduce nonspecific binding. After centrifugation, the supernatants were incubated for 18 h at 4°C with either 2 Ml of polyclonal anti-CAT antibody (Five Prime to Three Prime, Inc., Boulder, CO) or 10 ML polyclonal rabbit anti-human CgA antiserum (22) . After incubation with 20 Ml of 50% protein A Sepharose for 2 h at 4°C and centrifugation, the pellets were washed, boiled for 5 min, and electrophoresed through 8% SDS-polyacrylamide gels. The gels were placed in the enhancing solution Resolution (EM Corp., Chestnut Hill, MA) for 45 min, then placed in 5% cold glycerol for 45 minutes, dried, and exposed at -80°C to Kodak X-OMAT AR film (Eastman Kodak Co., Rochester, NY).
Secretagogue stimulation of transiently transfected cells. 48-60 h after transfection with the above constructs, PC-12 cells, grown in poly-D-lysine-coated polystyrene dishes (Falcon Labware), were labeled for 2 h with [3H]norepinephrine at 1 MCi/ml in PC-12 medium, washed twice with release buffer ( 150 mM NaCl, 5 mM KCl, 10 mM Hepes, pH 7), and incubated at room temperature for 30 min in 1 ml ofrelease buffer with or without the secretagogue barium chloride at 2 mM. After aspirating the release buffer, cells were harvested in 1 ml of 150 mM NaCl, 5 mM KCl, 10 mM Hepes, pH 7, and lysed with three freezethaw cycles. Release buffer and cell lysates were assayed for [3H1-norepinephrine by liquid scintillation counting and for CAT activity by the method oforganic extraction with ethyl acetate (33) . Briefly, the CAT activity assay mixture contained (in a final volume of250 Ml) 177 Ml of 50 mM Tris-HCl, pH 7. [ 34 ] ) encoding the v-sis signal peptide (34) , was inserted between the RSV-LTR promoter and the coding region for CAT. The final construct contains the coding region for the amino-terminal 59 amino acid residues of v-sis, fused in-frame to the full-length coding region for CAT, under the control ofthe RSV-LTR. As for all other plasmid constructions, the vector was analyzed by restriction endonuclease mapping to confirm orientations, and fragment junctions were confirmed by DNA sequencing.
Statistics
Results of secretion experiments are expressed as mean±SEM. Results were analyzed by ANOVA followed by Student-Newman-Keuls posthoc tests for multiple comparisons (37) .
Results
Expression ofhuman CgA in PC-12 cells Human CgA immunoreactivity was detected in cell homogenates from five of six recovered clones of PC-12 cells co-transfected with pRSV-hCgA and pSV2-neo and in none of six recovered clones of PC-12 cells transfected with pSV2-neo alone as a control. Fig. 3 shows Western blot analysis demonstrating expression of human CgA in stably transfected rat pheochromocytoma PC-12 cells (clone 2C). Human CgA is observed as an Mr 75-kD band crossreacting with a species-specific anti-human CgA antibody in cells cotransfected with pRSV-hCgA and pSV2-neo, but not in control cells transfected with pSV2-neo alone (clone 4A).
Electron microscopy
Transmission electron micrographs of PC-12 cells cotransfected with pRSV-hCgA and pSV2-neo are shown in Fig. 4 , demonstrating normal-appearing dense core secretory vesicles in a typical distribution at the cell periphery. Cell appearance, number, and distribution of dense core secretory vesicles did not differ from cells transfected with pSV2-neo alone or from wild-type PC-12 cells (data not shown).
Subcellular localization studies Sucrosegradient studies. To investigate the subcellular localization of the expressed human CgA in PC-12 cells transfected with pRSV-hCgA and pSV2-neo, cells were subjected to sucrose density gradient fractionation, the results of which are shown in Fig. 5 . In cells transfected with pRSV-hCgA and secretagogue-mediated corelease of CAT activity and norepinephrine as an index of targeting into the regulated secretory pathway. Fig. 9 human CgA. Expression of CgA was demonstrated in cell lysates of transfected cells by a species-specific human CgA RIA and by Western blotting with a species-specific anti-human CgA antiserum (Fig. 3) . (24) (25) (26) . Nonetheless, the peak at 1.3-1.4 M sucrose is consistent with the buoyant density previously demonstrated for chromaffin granules isolated from PC-12 cells (1.2-1.4 M sucrose) (24, 25) .
We used several well-established chromaffin-cell exocytotic secretagogues to assess the subcellular location of transfected human CgA. Since only proteins correctly targeted to granules are responsive to secretagogue, the extent of secretagogue-induced release relative to basal secretion is a measure of the efficiency at which the protein is targeted to the regulated pathway (54) . Stimulation of human CgA-expressing PC-12 cells with the nicotinic agonist carbachol, potassium chloride, or barium chloride all resulted in cosecretion of human CgA and catecholamines ( Figure 6 ).
In these secretion studies ( Figure 6 ), we found a consistent disparity between the percentage of norepinephrine and the percentage of CgA released in response to secretagogue, with greater values for norepinephrine release in all cases. We previously demonstrated time-dependent differences between catecholamine release and CgA release from chromaffin cells (55 (Fig. 6) showed parallel secretion ofnorepinephrine and CgA such that each increment in norepinephrine release was associated with a corresponding increase in CgA release, consistent with colocalization of norepinephrine and CgA to the same subcellular pool. Colocalization of norepinephrine and transfected CgA to the same subcellular fraction was also supported by sucrose density gradients (Fig. 5) . (Fig. 7) . Catecholamine storage vesicles and other neurosecretory granules are characterized by the presence of a proton pumping ATPase which maintains an acidic intravesicular pH (pH = 5) essential for concentration of catecholamines (59) . Disruption ofthe proton gradient by weak bases such as chloroquine and ammonium chloride depletes cells of catecholamines by nonexocytotic catecholamine release, without affecting the intravesicular composition of proteins synthesized and sorted before addition of alkalinizing agent (38) . If expressed human CgA is correctly targeted to the regulated secretory vesicle, then subsequent short-term exposure of PC-12 cells to weak bases would be expected to result in dissociation of release of catecholamines from that of CgA. Both chloroquine and ammonium chloride acutely released norepinephrine but not human CgA from transfected PC-12 cells (Fig. 7) , consistent with such a dissociation, and hence retention ofpreviously sorted CgA in catecholamine storage vesicles in the face of this nonexocytotic stimulus. Longer exposure to these compounds may divert newly synthesized regulated proteins away from dense core secretory vesicles (60) .
We also tested whether human CgA could divert an ordinarily nonsecreted heterologous protein to the catecholamine storage vesicle. To accomplish this aim, we fused human CgA in-frame to the bacterial CAT gene. Under normal circumstances, the CAT enzyme is not found in eukaryotic cells. When expression vectors encoding CAT are transfected into mammalian cells, the expressed protein is cytoplasmic, distributed diffusely throughout the cytosol (30, (61) (62) (63) . In our experiments, expressed CgA/CAT fusion products were of the appropriate predicted mobility on SDS-PAGE and were immunoprecipitated with both anti-human CgA and anti-CAT antibodies (Fig. 8) , confirming their chimeric structure. We then evaluated the subcellular distribution ofthese products by assessing corelease of norepinephrine and CAT activity as an index of the secretagogue-dependent releasable pool, i.e., the ( 14) . Peptide sequence information is from Konecki et al. (40) and Helman et al. ( 18) as analyzed previously by Parmer et al. (44) . regulated secretory pathway. In cells transfected with pRSV-CAT, exposure to barium did not release CAT activity (Fig. 9) , consistent with a cytosolic distribution of expressed CAT (30, (61) (62) (63) . On the other hand, when CgA was fused to CAT, a four-to fivefold increment in CAT activity was detected in the release medium after barium (Fig. 9) , consistent with targeting of the fusion protein into the regulated secretory pathway. Moreover, fusion of the amino-terminal 226 amino acid residues of human CgA to CAT also caused a four-to fivefold increment in CAT release after barium. Thus, CgA was capable of diverting CAT into the regulated secretory pathway, and sufficient information for this event is located in CgA's aminoterminal 226 amino acid residues. Ofnote, the ratio ofbariumstimulated to basal release percentages for the chimeric proteins was 4.6 for hCgA457CAT and 4.9 for hCgA226CAT (Fig. 9 , upper panel), compared with a ratio of 16.9 for human CgA alone (Fig. 6) Results of our CgA/CAT chimera studies are consistent with previous findings on chimeric polypeptides in which fusion of a regulated secretory protein to a heterologous protein resulted in diversion of the latter into the regulated pathway in other secretory cell types (66) (67) (68) (69) . Using another approach, Rosa et al. (70) introduced (by mRNA injection) antibodies to chromogranin B (secretogranin I) into PC-12 cells and demonstrated that these antibodies were bound to endogenous chromogranin B and diverted into the regulated pathway. Taken together, these results are consistent with the hypothesis that the targeting of proteins into secretory granules is an active, dominant, signal-mediated process. The trans-Golgi network plays an important role in the process of sorting proteins into the regulated secretory pathway (71) (72) (73) (74) . Two possible mechanisms have been proposed for targeting into the regulated pathway and for sorting regulated secretory proteins away from constitutive proteins at the trans-Golgi cisternae: (a) receptormediated protein targeting and (b) selective protein aggregation and condensation. In the first mechanism, correct targeting to the regulated pathway results from specific binding to carrier proteins or receptors in the Golgi membrane (75) which recognize sorting signals on targeted proteins. Alternatively, in the second mechanism, sorting of regulated secretory products from other soluble (constitutive) proteins in the pathway results from formation of molecular aggregates triggered by conditions in the trans-Golgi region (acidic pH and millimolar concentrations of calcium ions) (12, 76) . Chanat and Huttner (76) demonstrated that selective aggregation of proteins of the chromogranin / secretogranin ("granin") family could be induced by a low pH and high calcium milieu corresponding to that in the trans-Golgi network lumen. Indeed, this propensity for aggregation was remarkably selective for the granins, suggesting that the granin family may play a crucial role in packaging other polypeptides into the regulated pathway by molecular "hitchhiking" (77) or binding to the aggregated granin complex (12) . Since postranslational modification of the chromogranins was not necessary to promote their aggregative properties, the structural features important for aggregation seem to reside in the polypeptide backbone of these proteins (76) . Thus, either mechanism (receptor-dependent targeting or selective aggregation), could be mediated or facilitated by a specific region or regions within the primary structure of CgA. Moreover, our fusion studies suggest that sufficient information for targeting is provided by the amino-terminal portion of CgA.
Previous studies have revealed specific targeting domains for proteins destined for a variety of subcellular locations, including the endoplasmic reticulum (78), Golgi complex (79), lysosomes (80) , mitochondria (81) , peroxisomes (61, 62) , and nucleus (82) . However, studies to identify targeting signals for sorting to the regulated pathway of secretion have been inconsistent. For example, whereas the pro segment of prosomatostatin may contain important information for targeting to the regulated pathway (68, 69, 83) , mutagenesis studies have thus far failed to reveal discrete, regulated vesicular targeting sequences for a variety of regulated secretory proteins including proinsulin (54) , prorenin (84, 85) , and proparathyroid hormone (86) .
What specific domains, particularly within the amino-terminus ofCgA, might function in targeting CgA into dense core secretory granules? Structural features contained in the aminoterminal 226 amino acid residues of CgA (that portion of CgA encoded by pRSV-hCgA226CAT) include the 18-residue amino-terminal signal peptide (residues -18 to -1), two cysteine residues (residues + 17 and +38), a consensus sequence for N-linked glycosylation (NQS, residues +92 to +94), a 20 amino acid chromostatin sequence (residues + 124 to + 143) (14) , and an oligoglutamic acid cluster (residues + 154 to + 161) (Fig. 10) . Of note, CgA is an extremely hydrophilic protein with the exception oftwo hydrophobic regions that are well conserved across species. In addition to the 18-residue signal peptide (which is cleaved during cotranslational movement of the protein across the endoplasmic reticulum), a short hydrophobic area occurs near the amino terminus in the region bounded by the two cysteine residues at positions + 17 and +38 in the mature protein after signal peptide cleavage (44) . These cysteine residues form an intramolecular disulfide loop (87) , and the conserved hydrophobic character of this region, given the otherwise quite hydrophilic quality of CgA, has suggested that this domain may interact with Golgi membranes during targeting of CgA to secretory vesicles (44) . Recent analysis of the CgA gene by our group showed that CgA's eight exons correspond in part to putative functional domains suspected within the cDNA-deduced primary structure of the protein (88) . It is intriguing that the hydrophobic disulfide loop region is contained within exon 3 (residues + 14 to +45) (88) , which shares length and partial sequence homology with the disulfide loop-encoding (87) exon 3 ofchromogranin B (88), suggesting a conserved structure-function relationship for this region. (Chromogranin B is also efficiently targeted to the catecholamine storage vesicles in chromaffin cells [12, 56, 70, 76] .) Alternatively, several oligoglutamic acid regions are present within the primary structure of CgA. These areas contribute to the acidic nature of the protein and may interact with calcium ions and other cations [9, 45-47, 50, 76] 
